ArticleACS omega2026
Reading between the Chains: Surface Mapping and Druggable Pockets on the Biological Assemblies of DENV-2's Protein E.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue is a widespread arboviral infection endemic to tropical and subtropical regions, representing a major global public health concern. Although most prevalent in South America and Asia, cases have also emerged in Europe and the United States, including instances of local transmission and fatalities. The envelope protein (protein E) is a critical structural component of the viral surface and a well-established molecular target for antiviral drug discovery, owing to its essential role in viral entry. While previous studies have primarily focused on the β-OG pocket within isolated protein E dimers, the mature virion features a complex icosahedral organization composed of protein E dimers adopting distinct assemblies, which might expose novel pockets not present in the dimeric forms, offering new opportunities for structure-based drug design. In this study, we employed molecular dynamics simulations and structure-based computational analyses to identify and characterize druggable pockets on the external surface of protein E in its native oligomeric states. Side chain conformational sampling revealed distinct side chain dynamics and enabled the selection of representative structures for pocket mapping. Several druggable and borderline druggable pockets were identified, including sites encompassing residues such as Lys291, Lys295, and Pro384key mediators of protein E interaction with host membrane receptors. Additionally, residues such as Glu172, Thr180, Thr303, and Glu383 were found within druggable pockets, supporting their potential inclusion in pharmacophore models. These findings offer valuable insights for pharmacophore modeling and drug repurposing initiatives.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.